Qube Research & Technologies LTD Inogen Inc Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Inogen Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 52,731 shares of INGN stock, worth $605,351. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,731Holding current value
$605,351% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding INGN
# of Institutions
144Shares Held
20.8MCall Options Held
119KPut Options Held
149K-
Camber Capital Management LP Boston, MA2MShares$23 Million0.62% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$18.7 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.56MShares$17.9 Million0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.5MShares$17.2 Million0.0% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL1.06MShares$12.1 Million1.38% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $263M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...